Evidence map›Paper›PMID 42135761›Full record

ReviewJournal of translational medicine2026

Advances in near-infrared fluorescent probes for the tumor microenvironment.

Haodong Hu, Changyue Zhang, Xiaoqi Kong, Ye Chen, Ruijiao Chen

Abstract readReview
In one paragraph

Review in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haodong HuCollege of Medical Imaging and Laboratory, Jining Medical University, Jining, 272067, China.
Changyue ZhangCollege of Medical Imaging and Laboratory, Jining Medical University, Jining, 272067, China.
Xiaoqi KongCollege of Medical Imaging and Laboratory, Jining Medical University, Jining, 272067, China.
Ye ChenCollege of Medical Imaging and Laboratory, Jining Medical University, Jining, 272067, China.
Ruijiao ChenCollege of Medical Imaging and Laboratory, Jining Medical University, Jining, 272067, China. chenrj@mail.jnmc.edu.cn.ORCID 0000-0002-8855-3464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCancer remains a major threat to human health worldwide, but with progress in early diagnosis and treatment technology, the progression of cancer has been effectively slowed. Near-infrared (NIR) fluorescent probes are noninvasive imaging tools that show great promise for early tumor detection and intra-operative guidance due to their high sensitivity, deep tissue penetration, and high signal-to-noise ratio. MAIN BODY: In recent years, the rapid development of NIR fluorescent probes has been driven by a growing understanding of the unique characteristics of the tumor microenvironment. Targeting these features, such as pH, viscosity, polarity, hypoxia, and enzymes, has become a key strategy in the rational design of sensitive small-molecule fluorescent probes for cancer diagnosis and therapy. In this review, we have summarized the recent progress in NIR fluorescent probes for the tumor microenvironment, with an emphasis on their design principles, imaging performance, potential applications, and the challenges faced in clinical translation.

conclusionsDespite certain progress in near-infrared fluorescent probes, challenges remain, such as tumor heterogeneity and clinical translation. Future efforts should focus on multi-responsive designs, improved photostability, and multimodal imaging strategies. We hope this review can provide a valuable reference for the development of novel fluorescent probes.

Indexed as

Fluorescent DyesInfrared RaysTumor MicroenvironmentAnimalsHumansNeoplasmsSpectroscopy, Near-InfraredFluorescent DyesCancer markerNIR fluorescent probeTumor microenvironment

Identifiers

PMID42135761
PMCPMC13343694

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.